Clinical Trial Update: Safety and Effectiveness Study of Tumor Cell-derived Microparticles to Treat Malignant Ascites and Pleural Effusion [Phase 2]

View source ↗

Summary

Phase 2 safety and effectiveness study evaluating tumor cell-derived microparticles for malignant ascites and malignant pleural effusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Ascites
• Malignant Pleural Effusion

Drugs mentioned

• Tumor cell-derived microparticles

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Malignant Pleural Effusion,, Malignant Ascites | Phase 2 | Status: UNKNOWN